Gahart's 2021 Intravenous Medications - E-Book

A Handbook for Nurses and Health Professionals
 
 
Elsevier (Verlag)
  • 37. Auflage
  • |
  • erschienen am 10. Juli 2020
  • |
  • 1472 Seiten
 
E-Book | ePUB mit Adobe-DRM | Systemvoraussetzungen
978-0-323-75739-3 (ISBN)
 

The essential information you need to safely administer more than 400 intravenous drugs A Handbook for Nurses and Health Professionals has been a trusted resource for comprehensive drug coverage, unparalleled accuracy, and an intuitive quick-access format. In addition to updated drug interactions, precautions, alerts, and patient teaching instructions for all existing IV drugs, this new 37th edition includes more than a dozen new monographs of the most recent IV drugs to be approved by the FDA. Administering intravenous drugs is a critical task - inaccurate or out-of-date information is not an option. Known as the #1 IV drug handbook on the market, Gahart's annual publication, with its history of impeccable accuracy, gives you the extra confidence and guidance you need to safely and effectively treat patients.

    • Monographs on more than 400 IV drugs offers an impressive breadth of coverage that goes well beyond any comparable drug reference.
    • Updated annual publication prevents you from referencing outdated information.
    • Additional drug monographs are housed on the companion Evolve website.
    • A 45-year history of impeccable accuracy reinforces the importance of safe IV drug administration.
    • The perfect depth of information equips you with everything that is needed by today's clinicians for safe administration of IV drugs - nothing more, nothing less.
    • Proven, clinically optimized format keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page.
    • Highlighted Black Box Warnings and relevant content make locating critical information fast and easy.
    • Special circumstances in blue-screened text call attention to important circumstances that may not warrant Black Box Warnings.
    • Life stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients.
    • Dilution and dosage charts within monographs provide quick access to essential clinical information.
    • Convenient, alphabetical format organizes all drug monographs by generic name, allowing you to find any drug in seconds.
      • NEW Drug monographs for 19 newly approved drugs by the FDA provides you with the most current drug information.
      • Updates on drug interactions, precautions, alerts, and more have been made throughout the guide to reflect all changes to existing medications.
      • Englisch
      • Philadelphia
      • |
      • USA
      • 11,25 MB
      978-0-323-75739-3 (9780323757393)
      weitere Ausgaben werden ermittelt
      • Front Cover
      • Inside Front Cover
      • How to use
      • HOW TO USE THIS BOOK
      • STEP 1
      • STEP 2
      • That's it!
      • Develop the "look it up" habit.
      • Front matter
      • Gahart's 2021INTRAVENOUS MEDICATIONS
      • Copyright
      • Dedication
      • NURSING AND PHARMACOLOGY CONSULTANTS
      • Reviewers
      • Preface
      • Table of Contents
      • Format and content of Intravenous Medications
      • Key to abbreviations
      • Important IV therapy facts
      • USUAL DOSE
      • DILUTION
      • INCOMPATIBILITIES
      • TECHNIQUES
      • RATE OF ADMINISTRATION
      • PATIENT EDUCATION
      • SIDE EFFECTS
      • Resources
      • PUBLICATIONS
      • WEBSITE RESOURCES
      • Generic drugs: A
      • A
      • ABATACEPT
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ABCIXIMAB
      • USUAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ACETAMINOPHEN
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ACETAZOLAMIDE SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ACETYLCYSTEINE INJECTION
      • USUAL DOSE (ADULT AND PEDIATRIC)
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ACYCLOVIR
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ADENOSINE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ADO-TRASTUZUMAB EMTANSINE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ALBUMIN (HUMAN)
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ALDESLEUKIN
      • USUAL DOSE (International units [IU])
      • DOSE ADJUSTMENTS
      • DILUTION (International units [IU])
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ALEMTUZUMAB
      • USUAL DOSE
      • Campath
      • Pretreatment:
      • Premedication:
      • Dose escalation:
      • Maintenance dose:
      • Anti-infective prophylaxis:
      • Lemtrada
      • Pretreatment:
      • Premedication: Corticosteroids:
      • Herpes prophylaxis:
      • Lemtrada:
      • First treatment course:
      • Second treatment course:
      • Subsequent treatment courses:
      • DOSE ADJUSTMENTS
      • Campath and Lemtrada
      • Campath
      • DILUTION
      • Campath
      • Lemtrada
      • Filters:
      • Storage: Campath:
      • Lemtrada:
      • Campath and Lemtrada:
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • Campath
      • Lemtrada
      • CONTRAINDICATIONS
      • Campath
      • Lemtrada
      • PRECAUTIONS
      • Campath and Lemtrada
      • Campath
      • Lemtrada
      • Monitor: Campath:
      • Lemtrada:
      • Patient Education: Campath and Lemtrada:
      • Campath:
      • Lemtrada:
      • Maternal/Child: Campath and Lemtrada:
      • Campath:
      • Lemtrada:
      • Elderly: Campath:
      • Lemtrada:
      • DRUG/LAB INTERACTIONS
      • Campath and Lemtrada
      • Campath
      • Lemtrada
      • SIDE EFFECTS
      • Campath
      • Lemtrada
      • Post-Marketing: Campath:
      • Lemtrada:
      • ANTIDOTE
      • Campath and Lemtrada
      • Campath
      • Lemtrada
      • ALLOPURINOL SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ALPROSTADIL
      • USUAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ALTEPLASE
      • USUAL DOSE
      • Acute Myocardial Infarction
      • Accelerated infusion:
      • 3-hour infusion:
      • Acute Ischemic Stroke
      • Pulmonary Embolism
      • Central Venous Access Device (CVAD) Occlusions, Cathflo Activase
      • Patient weight 30 kg or greater:
      • Patient weight less than 30 kg:
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • AMIKACIN SULFATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEWBORN DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • AMINOCAPROIC ACID
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • AMINOPHYLLINE
      • USUAL DOSE
      • Bronchodilation in Acute Asthma or Bronchospasm
      • Adults, children, infants, and neonates who have not received a theophylline preparation in the previous 24 hours:
      • Adults, children, infants, and neonates who have received a theophylline preparation in the previous 24 hours: A serum the ...
      • Maintenance infusion:
      • Reverse Adenosine-Mediated Effects of Dipyridamole in Adults (Unlabeled)
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • AMIODARONE HYDROCHLORIDE
      • USUAL DOSE
      • Treatment and Prophylaxis of Ventricular Tachycardia (VT) and Ventricular Fibrillation (VF)
      • Rapid loading infusion:
      • Slow loading infusion:
      • Maintenance infusion:
      • Treatment of Breakthrough Ventricular Fibrillation (VF) or Hemodynamically Unstable Ventricular Tachycardia (VT)
      • Cardiac Arrest (unlabeled)
      • Supraventricular Arrhythmias (unlabeled)
      • Intravenous to Oral Transition
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • AMPHOTERICIN B **The Black Box Warning applies only to the generic formulation. ■ AMPHOTERICIN B LIPID-BASED PRODUCTS
      • USUAL DOSE
      • Abelcet (Amphotericin B Lipid Complex Injection)
      • Adults and pediatric patients:
      • AmBisome (Amphotericin B Liposome for Injection)
      • Adults, children, and infants over 1 month of age:
      • Empirical therapy in febrile, neutropenic patients:
      • Systemic fungal infections (e.g., Aspergillus, Candida, Cryptococcus):
      • Treatment of cryptococcal meningitis in HIV-infected patients:
      • Visceral leishmaniasis in immunocompetent patients:
      • Visceral leishmaniasis in immunocompromised patients:
      • Generic (Conventional Amphotericin B)
      • Adults and pediatric patients:
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • All Formulations
      • Abelcet
      • AmBisome/Generic
      • Generic (Conventional)
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • AMPICILLIN SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • AMPICILLIN SODIUM AND SULBACTAM SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ANGIOTENSIN II INJECTION
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ANIDULAFUNGIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ANTIHEMOPHILIC FACTOR (HUMAN ■ RECOMBINANT ■ RECOMBINANT [Fc FUSION PROTEIN] ■ RECOMBINANT [PEGYLATED] ...
      • USUAL DOSE (International units [IU])
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ANTIHEMOPHILIC FACTOR ■ VON WILLEBRAND FACTOR COMPLEX (HUMAN)
      • USUAL DOSE (International units [IU])
      • Alphanate
      • Treatment of hemophilia A (adults):
      • Humate-P
      • Treatment of hemophilia A (adults):
      • Treatment of von Willebrand Disease (vWD) (adults and pediatric patients):
      • Prevention of excessive bleeding during and after surgery in vWD:
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • Alphanate
      • Humate-P
      • CONTRAINDICATIONS
      • Alphanate:
      • Humate-P:
      • PRECAUTIONS
      • Alphanate and Humate-P:
      • Monitor:
      • Patient Education:
      • Maternal/Child:
      • Elderly:
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • Alphanate and Humate-P:
      • Post-Marketing:
      • ANTIDOTE
      • ANTI-INHIBITOR COAGULANT COMPLEX
      • USUAL DOSE
      • Feiba
      • Joint hemorrhage:
      • Mucous membrane bleeding:
      • Serious soft tissue hemorrhage:
      • Other severe hemorrhage (e.g., CNS bleeding):
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ANTITHROMBIN III (HUMAN)
      • USUAL DOSE (International units [IU])
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ANTITHROMBIN RECOMBINANT
      • USUAL DOSE (International units [IU])
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ANTI-THYMOCYTE GLOBULIN (RABBIT)
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • APREPITANT
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ARGATROBAN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ARSENIC TRIOXIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ATEZOLIZUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ATROPINE SULFATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • AVELUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • AZACITIDINE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • AZITHROMYCIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • AZTREONAM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • Generic drugs: B
      • B
      • BASILIXIMAB
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • BELATACEPT
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • BELIMUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • BELINOSTAT
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • BENDAMUSTINE HYDROCHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • BEVACIZUMAB ■ BEVACIZUMAB-awwbaaPlease see p. x for more information on biosimilars. ■ BEVACIZUMAB-bvzra
      • USUAL DOSE
      • Bevacizumab products
      • Metastatic colorectal cancer (mCRC):
      • First-line non-squamous, non-small-cell lung cancer (NSCLC):
      • Recurrent glioblastoma:
      • Metastatic renal cell carcinoma (mRCC):
      • Persistent, recurrent, or metastatic cervical cancer:
      • Bevacizumab (Avastin)
      • Stage III or IV epithelial ovarian, fallopian tube, or primary peritoneal cancer after initial surgical resection:
      • Platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer:
      • Platinum-sensitive recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer:
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • Bevacizumab products
      • Bevacizumab (Avastin)
      • Limitation of use:
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • BEZLOTOXUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • BIVALIRUDIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • BLEOMYCIN SULFATE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • BLINATUMOMAB
      • USUAL DOSE
      • Relapsed or refractory B-cell precursor (acute) lymphoblastic leukemia (ALL)
      • Premedication: Adults:
      • Pediatric patients:
      • Blinatumomab dosage:
      • Treatment of Minimal Residual Disease (MRD)-Positive B-cell Precursor (ALL)
      • Premedication: Adults:
      • Pediatric patients:
      • Blinatumomab dosage:
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • BORTEZOMIB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • BRENTUXIMAB VEDOTIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • BRIVARACETAM
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • BUMETANIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • BUPRENORPHINE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • BUSULFAN
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • BUTORPHANOL TARTRATE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic drugs: C
      • C
      • C1 ESTERASE INHIBITOR (HUMAN OR RECOMBINANT)
      • USUAL DOSE (International units [IU])
      • Berinert
      • Treatment of an acute attack:
      • Cinryze
      • Routine prophylaxis dosing:
      • Ruconest
      • Treatment of an acute attack:
      • DILUTION
      • Berinert
      • Cinryze
      • Ruconest
      • Filters: Berinert:
      • Cinryze and Ruconest:
      • Storage: All Formulations:
      • Berinert:
      • Cinryze:
      • Ruconest:
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CABAZITAXEL
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CAFFEINE CITRATE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CALASPARGASE PEGOL-mknl
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CALCITRIOL
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CALCIUM CHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CALCIUM GLUCONATE
      • USUAL DOSE
      • PEDIATRIC AND NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CANGRELOR
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CARBAMAZEPINE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CARBOPLATIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CARFILZOMIB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CARMUSTINE (BCNU)
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CASPOFUNGIN ACETATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CEFAZOLIN SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CEFEPIME HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CEFOTAXIME SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CEFOTETAN DISODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CEFOXITIN SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE (unlabeled)
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CEFTAROLINE FOSAMIL
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CEFTAZIDIME
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CEFTAZIDIME/AVIBACTAM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CEFTOLOZANE/TAZOBACTAM
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CEFTRIAXONE SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CEFUROXIME SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CEMIPLIMAB-rwlc
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CETUXIMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CHLORPROMAZINE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CIDOFOVIR INJECTION
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CIPROFLOXACIN
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CISATRACURIUM BESYLATE
      • USUAL DOSE
      • Adjunct to Propofol/N2O/O2 Anesthesia for Adults (IV Bolus)
      • Initial dose:
      • Maintenance dose:
      • Continuous infusion:
      • Support of Intubated, Mechanically Ventilated Adult ICU Patients
      • PEDIATRIC DOSE
      • Adjunct to Halothane or Opioid Anesthesia for Pediatric Patients 1 Month to 23 Months of Age
      • Adjunct to Halothane or Opioid Anesthesia for Pediatric Patients 2 to 12 Years of Age
      • Initial dose:
      • Maintenance dose:
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CISPLATIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CLADRIBINE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CLEVIDIPINE BUTYRATE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CLINDAMYCIN PHOSPHATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CLOFARABINE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • COAGULATION FACTOR VIIa (RECOMBINANT) RTS
      • USUAL DOSE
      • Hemophilia A or B Patients with Inhibitors
      • Bleeding episodes:
      • Surgical intervention:
      • Congenital Factor VII Deficiency Patients
      • Bleeding episodes and surgical intervention:
      • Acquired Hemophilia
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • COAGULATION FACTOR X (HUMAN)
      • USUAL DOSE (INTERNATIONAL UNITS [IU])
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • COAGULATION FACTOR Xa (RECOMBINANT), INACTIVATED-zhzo
      • USUAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • COAGULATION FACTOR XIII A-SUBUNIT (RECOMBINANT)
      • USUAL DOSE (International units [IU])
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CONIVAPTAN HYDROCHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • COPANLISIB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • COSYNTROPIN
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CYCLOPHOSPHAMIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CYCLOSPORINE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CYTARABINE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CYTOMEGALOVIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN) **This drug is on the Black Box Warning list
      • however, a BBW is not pr ...
      • USUAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • Generic drugs: D
      • D
      • DACARBAZINE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DALBAVANCIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DANTROLENE SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DAPTOMYCIN
      • USUAL DOSE
      • All Formulations
      • Complicated skin and skin structure infections (cSSSI):
      • Staphylococcus aureus bloodstream infections (bacteremia), including those with right-sided endocarditis:
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • Cubicin RF
      • Adults:
      • Pediatric patients 7 to 17 years of age (30-minute infusion):
      • Pediatric patients 1 to 6 years of age (60-minute infusion):
      • Filters:
      • Storage: Cubicin and generics:
      • Cubicin RF:
      • All formulations:
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • All Formulations
      • Injection: Adults:
      • Infusion: Adults:
      • Pediatric patients 7 to 17 years of age:
      • Pediatric patients 1 to 6 years of age:
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DARATUMUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DARBEPOETIN ALFA
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DAUNORUBICIN AND CYTARABINE LIPOSOME FOR INJECTION
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DAUNORUBICIN HYDROCHLORIDE ■ DAUNORUBICIN CITRATE LIPOSOMAL INJECTION
      • USUAL DOSE
      • All Daunorubicins
      • Pretreatment:
      • Conventional Daunorubicin
      • Adult acute nonlymphocytic leukemia:
      • Adult acute lymphocytic leukemia:
      • DaunoXome (Liposomal Injection)
      • Advanced, HIV-associated Kaposi's sarcoma:
      • PEDIATRIC DOSE
      • Conventional Daunorubicin
      • Acute lymphocytic leukemia in pediatric patients 2 years of age and older:
      • Acute lymphocytic leukemia in infants and children under 2 years of age or less than 0.5 M2 body surface:
      • DaunoXome:
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • Conventional Daunorubicin
      • DaunoXome
      • RATE OF ADMINISTRATION
      • Conventional Daunorubicin
      • IV injection:
      • IV infusion:
      • DaunoXome
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DECITABINE FOR INJECTION
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DELAFLOXACIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DESMOPRESSIN ACETATE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DEXAMETHASONE SODIUM PHOSPHATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DEXMEDETOMIDINE HYDROCHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DEXRAZOXANE
      • USUAL DOSE
      • Totect
      • Day 1 and Day 2:
      • Day 3:
      • Zinecard
      • DOSE ADJUSTMENTS
      • Totect and Zinecard
      • Zinecard
      • DILUTION
      • Totect
      • Preparation of Totect, using SWFI and LR:
      • Preparation of Totect, using 0.167 M sodium lactate injection and NS:
      • Zinecard
      • Storage: Totect and Zinecard:
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • Totect
      • Zinecard
      • ACTIONS
      • Dexrazoxane
      • Totect
      • Zinecard
      • INDICATIONS AND USES
      • Totect
      • Zinecard
      • CONTRAINDICATIONS
      • Totect
      • Zinecard
      • PRECAUTIONS
      • Totect and Zinecard
      • Totect
      • Zinecard
      • Monitor: Totect and Zinecard:
      • Totect:
      • Zinecard:
      • Patient Education:
      • Maternal/Child:
      • Elderly:
      • DRUG/LAB INTERACTIONS
      • Totect and Zinecard
      • Totect
      • Zinecard
      • SIDE EFFECTS
      • ANTIDOTE
      • DEXTRAN HIGH MOLECULAR WEIGHT
      • USUAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DEXTRAN LOW MOLECULAR WEIGHT
      • USUAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DEXTROSE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DIAZEPAM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DICLOFENAC SODIUM
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DIGOXIN
      • USUAL DOSE
      • Loading dosing regimen in adults and pediatric patients:
      • Maintenance dosing in adults and pediatric patients over 10 years of age:
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DIGOXIN IMMUNE FAB (OVINE)
      • USUAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DIHYDROERGOTAMINE MESYLATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DILTIAZEM HYDROCHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DINUTUXIMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DIPHENHYDRAMINE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DIPYRIDAMOLE
      • USUAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DOBUTAMINE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DOCETAXEL
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DOPAMINE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DORIPENEM
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DOXERCALCIFEROL
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DOXORUBICIN HYDROCHLORIDE ■ DOXORUBICIN HYDROCHLORIDE LIPOSOMAL INJECTION
      • USUAL DOSE
      • Conventional Doxorubicin
      • Breast cancer with lymph node involvement after resection:
      • Adjuvant treatment of operable node-positive breast cancer:
      • Doxil (Liposomal Doxorubicin)
      • AIDS-related Kaposi's sarcoma:
      • Ovarian cancer:
      • Multiple myeloma:
      • Bortezomib:
      • Doxil:
      • Breast cancer (unlabeled):
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • Conventional Doxorubicins:
      • Breast cancer with lymph node involvement after resection:
      • Doxil:
      • DILUTION
      • COMPATIBILITY
      • Conventional Doxorubicin
      • Doxil
      • RATE OF ADMINISTRATION
      • Conventional Doxorubicin
      • IV injection:
      • Continuous infusion:
      • Doxil
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • All Doxorubicins:
      • Conventional Doxorubicin:
      • Doxil:
      • DOXYCYCLINE HYCLATE
      • USUAL DOSE
      • Adults and Pediatric Patients Weighing 45 kg or More
      • Primary and secondary syphilis:
      • Acute pelvic inflammatory disease:
      • Treatment of inhalational anthrax (postexposure):
      • PEDIATRIC DOSE
      • All Doses are For Pediatric Patients Weighing Less Than 45 kg
      • Treatment of inhalational anthrax (postexposure):
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DROPERIDOL
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • DURVALUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic drugs: E
      • E
      • ECULIZUMAB
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • EDARAVONE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ELOTUZUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • EMAPALUMAB-lzsg
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ENALAPRILAT
      • USUAL DOSE
      • PEDIATRIC DOSE (UNLABELED)
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • EPINEPHRINE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • EPIRUBICIN HYDROCHLORIDE
      • USUAL DOSE
      • Ellence
      • Pretreatment:
      • Premedication:
      • Epirubicin:
      • Pharmorubicin PFS
      • Metastatic breast cancer: Single agent:
      • Early-stage breast cancer (Stage II-IIIA):
      • Small-cell lung cancer: Single agent:
      • Non-small-cell lung cancer: Single agent:
      • Non-Hodgkin lymphoma: Single agent:
      • Hodgkin disease: Combination therapy:
      • Ovarian cancer: Single agent:
      • Locally unresectable or metastatic gastric cancer: Single agent:
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • EPOETIN ALFA , ■ EPOETIN ALFA-epbxa
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • EPOPROSTENOL SODIUM
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • EPTIFIBATIDE
      • USUAL DOSE
      • Acute Coronary Syndrome
      • Eptifibatide:
      • Aspirin:
      • Heparin: Medical management:
      • Patients undergoing PCI:
      • Percutaneous Coronary Intervention (PCI)
      • Eptifibatide:
      • Aspirin:
      • Heparin:
      • For Both Indications
      • DOSE ADJUSTMENTS
      • Acute Coronary Syndrome
      • PCI
      • All Diagnoses
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ERAVACYCLINE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ERIBULIN MESYLATE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ERTAPENEM
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ERYTHROMYCIN LACTOBIONATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ESMOLOL HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ESOMEPRAZOLE SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ETELCALCETIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ETEPLIRSEN
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ETOMIDATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ETOPOSIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • Nonphosphate Products (e.g., VePesid)
      • Phosphate Products (e.g., Etopophos)
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic Drugs: F
      • F
      • FACTOR IX (HUMAN) ■ FACTOR IX COMPLEX (HUMAN)
      • USUAL DOSE (International units [IU])
      • All Formulations
      • Minor hemorrhage:
      • Major trauma or surgery:
      • Dental extraction:
      • Prophylaxis:
      • Factor IX Complex
      • Reversal of coumarin effect:
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FACTOR IX (RECOMBINANT)
      • USUAL DOSE (International units [IU])
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FACTOR XIII CONCENTRATE (HUMAN)
      • USUAL DOSE (International units [IU])
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FAMOTIDINE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FAT EMULSION, INTRAVENOUS
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FENOLDOPAM MESYLATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FENTANYL CITRATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FERRIC CARBOXYMALTOSE INJECTION
      • USUAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FERUMOXYTOL
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FIBRINOGEN CONCENTRATE (HUMAN)
      • USUAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FILGRASTIM ■ FILGRASTIM-aafiaaPlease see p. x for more information on biosimilars. ■ FILGRASTIM-sndza
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FISH OIL TRIGLYCERIDES INJECTABLE EMULSION
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FLUCONAZOLE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FLUDARABINE PHOSPHATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FLUMAZENIL
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FLUOROURACIL
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FOSAPREPITANT DIMEGLUMINE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FOSCARNET SODIUM
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FOSNETUPITANT AND PALONOSETRON
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FOSPHENYTOIN SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FUROSEMIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic drugs: G
      • G
      • GANCICLOVIR SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • GEMCITABINE HYDROCHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • GEMTUZUMAB OZOGAMICIN
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • GENTAMICIN SULFATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • GLUCAGON
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • GLUCARPIDASE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • GLYCOPYRROLATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • GOLIMUMAB
      • USUAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • GRANISETRON HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic drugs: H
      • H
      • HEMIN
      • USUAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • HEPARIN SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • HEPATITIS B IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
      • USUAL DOSE (International units [IU])
      • DOSE ADJUSTMENTS (International units [IU])
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • HYDRALAZINE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • HYDROCORTISONE SODIUM SUCCINATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • HYDROMORPHONE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • HYDROXOCOBALAMIN
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic drugs: I
      • I
      • IBALIZUMAB-uiyk
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • IBANDRONATE SODIUM
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • IBUPROFEN
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • IBUPROFEN LYSINE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • IBUTILIDE FUMARATE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • IDARUBICIN HYDROCHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • IDARUCIZUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • IFOSFAMIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • IMIPENEM-CILASTATIN
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • IMMUNE GLOBULIN INTRAVENOUS
      • USUAL DOSE
      • Primary Immunodeficiency (PID) Diseases
      • Bivigam and Gammuplex:
      • Carimune NF:
      • Flebogamma, Gammagard Liquid, Gammagard S/D, Gammaked, Gamunex-C, Octagam 5%, and Panzyga:
      • Privigen:
      • Idiopathic Thrombocytopenic Purpura (ITP)
      • Carimune NF:
      • Flebogamma 10%:
      • Gammagard S/D:
      • Gammaked and Gamunex-C:
      • Gammaplex, Octagam 10%, Privigen, and Panzyga: Chronic ITP:
      • B-Cell Chronic Lymphocytic Leukemia (CLL)
      • Gammagard S/D:
      • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
      • Gamunex-C and Gammaked: Loading dose:
      • Privigen: Loading dose:
      • Multifocal Motor Neuropathy (MMN)
      • Gammagard Liquid:
      • PEDIATRIC DOSE
      • Kawasaki Syndrome
      • Gammagard S/D:
      • Other Indications
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • INDOMETHACIN SODIUM
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • INFLIXIMAB ■ INFLIXIMAB-dyybaaPlease see p. x for more information on biosimilars. ■ INFLIXIMAB-abdaa ■ IN ...
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • INOTUZUMAB OZOGAMICIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • INSULIN HUMAN INJECTION (REGULAR) ■ INSULIN ASPART ■ INSULIN GLULISINE ■ INSULIN LISPRO
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • IPILIMUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • IRINOTECAN HYDROCHLORIDE ■ IRINOTECAN LIPOSOME INJECTION
      • USUAL DOSE
      • Conventional Irinotecan
      • Premedication: Antiemetics:
      • First-line treatment of colorectal cancer:
      • Treatment of colorectal cancer after failure of treatment with fluorouracil: Irinotecan:
      • Onivyde (Liposomal Irinotecan)
      • Premedication:
      • Metastatic adenocarcinoma of the pancreas:
      • DOSE ADJUSTMENTS
      • Conventional Irinotecan
      • Combination therapy:
      • Single-agent therapy:
      • ONIVYDE
      • DILUTION
      • COMPATIBILITY
      • Conventional Irinotecan
      • ONIVYDE
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • IRON DEXTRAN INJECTION
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • IRON SUCROSE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ISAVUCONAZONIUM SULFATE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ISOPROTERENOL HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • IXABEPILONE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • Generic drugs: K
      • K
      • KETOROLAC TROMETHAMINE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic drugs: L
      • L
      • LABETALOL HYDROCHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • LACOSAMIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • LETERMOVIR
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • LEUCOVORIN CALCIUM
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • LEVETIRACETAM INJECTION
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • LEVOFLOXACIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • LEVOLEUCOVORIN
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • LEVOTHYROXINE SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • LIDOCAINE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • LINEZOLID
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • LORAZEPAM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • LYMPHOCYTE IMMUNE GLOBULIN
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic drugs: M
      • M
      • MAGNESIUM SULFATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • MANNITOL
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • MELPHALAN HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • MEROPENEM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • MEROPENEM AND VABORBACTAM FOR INJECTION
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • MESNA
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • METHADONE HYDROCHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • METHOTREXATE SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • METHYLERGONOVINE MALEATE
      • USUAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • METHYLPREDNISOLONE SODIUM SUCCINATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • METOCLOPRAMIDE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • METOPROLOL TARTRATE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • METRONIDAZOLE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • MICAFUNGIN SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • Dosage for pediatric patients under 4 months of age: Treatment of candidemia, acute disseminated candidiasis, Candida per ...
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • Limitations of Use:
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • MIDAZOLAM HYDROCHLORIDE
      • USUAL DOSE
      • Sedation, Anxiolysis (Antianxiety), and/or Amnesia for Short Diagnostic, Endoscopic, and Therapeutic Procedures
      • Healthy adults under 60 years of age:
      • Patients over 60 years of age or debilitated or chronically ill patients:
      • Induction of Anesthesia Before Administration of Other Anesthetic Agents and/or Maintenance of Anesthesia as a Component o ...
      • Unpremedicated patients under 55 years of age:
      • Unpremedicated patients over 55 years of age (ASA I or II):
      • Unpremedicated debilitated patients or those with severe systemic disease (ASA III or IV):
      • Patients premedicated with sedatives or narcotics under 55 years of age:
      • Patients premedicated with sedatives or narcotics over 55 years of age (Good risk [ASA I & II]):
      • Patients premedicated with sedatives or narcotics who are debilitated or those with severe systemic disease (ASA III or IV):
      • Sedation for Anesthesia or Treatment in a Critical Care Setting for Intubated and Mechanically Ventilated Patients
      • Continuous infusion:
      • For maintenance of sedation:
      • Refractory Status Epilepticus (Unlabeled)
      • PEDIATRIC DOSE
      • Sedation, Anxiolysis (Antianxiety), and/or Amnesia Before and During Procedures or Before Anesthesia
      • Nonintubated infants under 6 months of age:
      • Pediatric patients 6 months to 5 years of age:
      • Pediatric patients 6 to 12 years of age:
      • Pediatric patients 12 to 16 years of age:
      • Sedation, Anxiolysis, Amnesia
      • Intubated pediatric patients in critical care settings:
      • Sedation of Intubated Neonates in Critical Care Settings
      • Neonates under 32 weeks:
      • Neonates 32 weeks or older:
      • Refractory Status Epilepticus (Unlabeled)
      • Pediatric patients 2 months of age or older:
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • MILRINONE LACTATE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • MITOMYCIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • MITOXANTRONE HYDROCHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • MOGAMULIZUMAB-kpkc
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • MORPHINE SULFATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • MOXETUMOMAB PASUDOTOX-tdfk
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • MOXIFLOXACIN HYDROCHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • MYCOPHENOLATE MOFETIL HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic drugs: N
      • N
      • NAFCILLIN SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • NALBUPHINE HYDROCHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • NALOXONE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • NATALIZUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • NECITUMUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • NELARABINE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • NEOSTIGMINE METHYLSULFATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • NICARDIPINE HYDROCHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • NITROGLYCERIN IV
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • NITROPRUSSIDE SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • NIVOLUMAB
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • NOREPINEPHRINE BITARTRATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic drugs: O
      • O
      • OBINUTUZUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • OCRELIZUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • OCTREOTIDE ACETATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • OFATUMUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • OLARATUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • OMADACYCLINE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ONDANSETRON HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ORITAVANCIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • OXALIPLATIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • OXYTOCIN INJECTION
      • USUAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic drugs: P
      • P
      • PACLITAXEL ■ PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION (ALBUMIN-BOUND)
      • USUAL DOSE
      • Conventional Paclitaxel
      • Premedication:
      • Ovarian cancer in previously untreated patients:
      • Ovarian cancer in patients previously treated with chemotherapy:
      • Adjuvant treatment of node-positive breast cancer:
      • Breast cancer in patients previously treated with chemotherapy:
      • First-line treatment of non-small-cell lung cancer:
      • AIDS-related Kaposi's sarcoma:
      • Abraxane
      • Premedication:
      • Metastatic breast cancer (MBC):
      • Non-small-cell lung cancer (NSCLC):
      • Adenocarcinoma of the pancreas:
      • DOSE ADJUSTMENTS
      • Conventional Paclitaxel
      • Abraxane
      • DILUTION
      • Conventional Paclitaxel
      • Abraxane
      • Filters: Conventional paclitaxel:
      • Storage: Conventional paclitaxel:
      • COMPATIBILITY
      • Conventional Paclitaxel
      • Abraxane
      • RATE OF ADMINISTRATION
      • Conventional Paclitaxel
      • Abraxane
      • ACTIONS
      • All Formulations
      • Conventional Paclitaxel
      • Abraxane
      • INDICATIONS AND USES
      • Conventional Paclitaxel
      • Abraxane
      • Unlabeled uses: Conventional paclitaxel:
      • CONTRAINDICATIONS
      • Conventional Paclitaxel
      • Abraxane
      • PRECAUTIONS
      • All Formulations
      • Conventional Paclitaxel
      • Abraxane
      • Monitor: All Formulations:
      • Conventional Paclitaxel:
      • Abraxane:
      • Patient Education: All Formulations:
      • Maternal/Child: All Formulations:
      • Conventional Paclitaxel:
      • Elderly: All Formulations:
      • Conventional Paclitaxel:
      • Abraxane:
      • DRUG/LAB INTERACTIONS
      • All Formulations
      • Conventional Paclitaxel
      • Abraxane
      • SIDE EFFECTS
      • Conventional Paclitaxel
      • Post-Marketing:
      • Abraxane
      • Post-Marketing:
      • ANTIDOTE
      • PALIFERMIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PALONOSETRON
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PAMIDRONATE DISODIUM
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PANITUMUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PANTOPRAZOLE SODIUM
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PAPAVERINE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PARICALCITOL
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PATISIRAN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • MATERNAL/CHILD:
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PEGASPARGASE ■ ASPARAGINASE Erwinia chrysanthemi
      • USUAL DOSE (International units [IU])
      • DOSE ADJUSTMENTS
      • DILUTION (International units [IU])
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PEGLOTICASE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PEMBROLIZUMAB
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PEMETREXED
      • USUAL DOSE
      • Premedication Required
      • Folic acid supplementation:
      • Vitamin B12 supplementation:
      • Corticosteroid:
      • Prehydration:
      • Pemetrexed
      • Malignant pleural mesothelioma:
      • Nonsquamous non-small-cell lung cancer (NSCLC): Initial treatment of locally advanced or metastatic NSCLC:
      • Maintenance treatment of locally advanced or metastatic NSCLC:
      • Treatment of recurrent/metastatic disease:
      • Initial treatment of metastatic NSCLC:
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PENICILLIN G AQUEOUS
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PENTAMIDINE ISETHIONATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PENTOBARBITAL SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PENTOSTATIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PERAMIVIR
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PERTUZUMAB
      • USUAL DOSE
      • Metastatic Breast Cancer (MBC)
      • Initial doses: Pertuzumab:
      • Trastuzumab:
      • Subsequent doses:
      • Pertuzumab:
      • Trastuzumab:
      • Docetaxel:
      • Neoadjuvant Treatment of Breast Cancer
      • Adjuvant Treatment of Breast Cancer
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PHENOBARBITAL SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PHENYLEPHRINE HYDROCHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PHENYTOIN SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PHOSPHATE
      • USUAL DOSE
      • INFANT DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • All Formulations
      • Potassium Phosphate
      • Sodium Phosphate
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PHYSOSTIGMINE SALICYLATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PHYTONADIONE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEWBORN DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PLAZOMICIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PORFIMER SODIUM
      • USUAL DOSE
      • Esophageal and Endobronchial Cancer
      • Esophageal cancer:
      • Endobronchial non-small-cell lung cancer:
      • High-Grade Dysplasia (HGD in Barrett's Esophagus [BE])
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • POSACONAZOLE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • POTASSIUM ACETATE AND POTASSIUM CHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PRALATREXATE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PROCAINAMIDE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PROCHLORPERAZINE EDISYLATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PROMETHAZINE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PROPOFOL INJECTION
      • USUAL DOSE
      • Induction of Anesthesia
      • Healthy adults under 55 years of age:
      • Adults over 55 years of age, debilitated, or ASA III or IV risk patients:
      • Cardiac anesthesia:
      • Neurosurgical patients:
      • Maintenance of Anesthesia
      • Adults under 55 years:
      • Adults over 55 years of age, debilitated, or ASA III or IV risk patients:
      • Cardiac anesthesia:
      • Neurosurgical patients:
      • Initiation of Monitored Anesthesia Care (MAC) Sedation
      • Healthy adults under 55 years of age:
      • Adults over 55 years of age, debilitated, or ASA III or IV risk patients:
      • Maintenance of MAC Sedation
      • Healthy adults under 55 years:
      • Adults over 55 years, debilitated, or ASA III or IV risk patients:
      • Sedation of Intubated, Mechanically Ventilated ICU Patients
      • Maintenance of Sedation in Mechanically Ventilated or Respiratory-Controlled ICU Patients
      • Relief of Pruritus Associated with Use of Spinal Opiates or Cholestasis (Unlabeled)
      • Management of Refractory Status Epilepticus (Unlabeled)
      • PEDIATRIC DOSE
      • Induction of Anesthesia in Healthy Pediatric Patients 3 to 16 Years of Age
      • Maintenance of Anesthesia in Healthy Pediatric Patients From 2 Months to 16 Years of Age
      • Pediatric patients 2 months of age and older:
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PROPRANOLOL HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE (UNLABELED)
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PROTAMINE SULFATE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PROTEIN AMINO ACIDS, DEXTROSE, FAT EMULSION, AND ELECTROLYTES
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • PROTHROMBIN COMPLEX CONCENTRATE (HUMAN)
      • USUAL DOSE (International Units [IU])
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic drugs: Q
      • Q
      • QUINUPRISTIN/DALFOPRISTIN
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic drugs: R
      • R
      • RAMUCIRUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • RANITIDINE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • RASBURICASE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • RAVULIZUMAB-cwvz
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • RESLIZUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • RETEPLASE RECOMBINANT
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Rho(D) IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
      • USUAL DOSE (International units [IU])
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS (International units [IU])
      • DILUTION (International units [IU])
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS (International units [IU])
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • RIFAMPIN
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • RITUXIMAB ■ RITUXIMAB-abbsaaPlease see p. x for more information on biosimilars. ■ RITUXIMAB-pvvra
      • USUAL DOSE
      • Rituximab Products
      • Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell non-Hodgkin lymphoma (NHL): Single agent: Initial t ...
      • Previously untreated follicular, CD20-positive, B-cell NHL:
      • Nonprogressing, low-grade, CD20-positive, B-cell NHL (after first-line CVP chemotherapy):
      • Diffuse large B-cell, CD20-positive NHL:
      • Chronic lymphocytic leukemia (CLL):
      • Granulomatosis with polyangiitis (GPA [Wegener's granulomatosis (WG)]) and microscopic polyangiitis (MPA):
      • Induction treatment of patients with active GPA/MPA: Methylprednisolone:
      • Rituximab:
      • Follow-up treatment (for patients with GPA/MPA who have achieved disease control with induction treatment): Methylprednisolone:
      • Therapeutic regimen with ibritumomab tiuxetan for treatment of NHL: Rituximab:
      • Rituxan and Truxima
      • Rheumatoid arthritis:
      • Rituxan
      • Component of the therapeutic regimen with ibritumomab tiuxetan (Zevalin) for treatment of NHL: Rituximab:
      • Pemphigus vulgaris:
      • PEDIATRIC DOSE
      • Rituxan
      • Induction treatment of pediatric patients with active GPA/MPA:
      • Follow-up treatment (for pediatric patients with GPA/MPA who have achieved disease control with induction treatment):
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ROMIDEPSIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic drugs: S
      • S
      • SARGRAMOSTIM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • SILDENAFIL **This drug is on the Black Box Warning list
      • however, a BBW is not provided in the parenteral prescribing info ...
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • SIPULEUCEL-T
      • USUAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • SODIUM ACETATE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • SODIUM BICARBONATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • SODIUM CHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • SODIUM FERRIC GLUCONATE COMPLEX
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • SOTALOL HYDROCHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • SUGAMMADEX
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • SULFAMETHOXAZOLE AND TRIMETHOPRIM
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic drugs: T
      • T
      • TACROLIMUS
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • TAGRAXOFUSP-erzs
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • TEDIZOLID PHOSPHATE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • TELAVANCIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • TEMOZOLOMIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • Temozolomide Dose Modification Table for Refractory Anaplastic Astrocytoma:
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • TEMSIROLIMUS
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • TENECTEPLASE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • TENIPOSIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • THIAMINE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • THIOTEPA
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • TIGECYCLINE FOR INJECTION
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • TIROFIBAN HYDROCHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • TISAGENLECLEUCEL
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • TOBRAMYCIN SULFATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • TOCILIZUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • TOPOTECAN HYDROCHLORIDE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • TRANEXAMIC ACID
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • TRASTUZUMAB ■ TRASTUZUMAB-dkstaaPlease see p. x for more information on biosimilars. ■ TRASTUZUMAB-dttba ...
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic drugs: V
      • V
      • VALPROATE SODIUM
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • VANCOMYCIN HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • VASOPRESSIN INJECTION
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • VECURONIUM BROMIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • VEDOLIZUMAB
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • VERAPAMIL HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • VINBLASTINE SULFATE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • VINCRISTINE SULFATE ■ VINCRISTINE SULFATE LIPOSOME INJECTION
      • USUAL DOSE
      • Conventional Vincristine
      • Marqibo (Liposomal Vincristine)
      • PEDIATRIC DOSE
      • Conventional Vincristine
      • Weight over 10 kg:
      • Weight 10 kg (22 lb) or less:
      • Marqibo (Liposomal Vincristine)
      • DOSE ADJUSTMENTS
      • Conventional Vincristine:
      • Marqibo (Liposomal Vincristine)
      • DILUTION
      • Conventional Vincristine:
      • Marqibo (Liposomal Vincristine):
      • Filters: Marqibo (liposomal vincristine):
      • Storage: Conventional vincristine:
      • Marqibo (liposomal vincristine):
      • COMPATIBILITY
      • Conventional Vincristine
      • Marqibo (Liposomal Vincristine)
      • RATE OF ADMINISTRATION
      • Conventional Vincristine
      • IV injection:
      • Infusion:
      • Marqibo (Liposomal Vincristine)
      • ACTIONS
      • Conventional Vincristine:
      • Marqibo (Liposomal Vincristine):
      • INDICATIONS AND USES
      • Conventional Vincristine:
      • Marqibo (Liposomal Vincristine):
      • Unlabeled uses: Conventional vincristine:
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • Both Formulations:
      • Conventional Vincristine:
      • Marqibo (Liposomal Vincristine):
      • Monitor: Both Formulations:
      • Patient Education: Both formulations:
      • Maternal/Child: Both formulations:
      • Marqibo (liposomal vincristine):
      • Elderly: Both formulations:
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • Conventional Vincristine:
      • Marqibo (Liposomal Vincristine):
      • ANTIDOTE
      • VINORELBINE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN)
      • USUAL DOSE (International Units [IU])
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • VON WILLEBRAND FACTOR (RECOMBINANT)
      • USUAL DOSE (International Units [IU])
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • VORICONAZOLE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • Generic drugs: Z
      • Z
      • ZIDOVUDINE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • NEONATAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ZOLEDRONIC ACID
      • USUAL DOSE
      • Reclast and Zometa
      • Pretreatment:
      • Reclast
      • Treatment of Paget's disease:
      • Calcium:
      • Vitamin D:
      • Treatment of osteoporosis in men and postmenopausal women and treatment and prevention of glucocorticoid-induced osteoporosis:
      • Prevention of osteoporosis in postmenopausal women:
      • Zometa
      • Hypercalcemia of malignancy (corrected serum calcium equal to or greater than 12 mg/dL [3 mmol/L]):
      • Multiple myeloma and metastatic bone lesions from solid tumors:
      • DOSE ADJUSTMENTS
      • Reclast and Zometa
      • Reclast
      • Zometa
      • Hypercalcemia of malignancy:
      • Multiple myeloma and metastatic bone lesions from solid tumors:
      • DILUTION
      • Reclast
      • Zometa
      • Single-use, ready-to-use-bottle:
      • Concentrate with 4 mg in 5 mL for single use:
      • Filters:
      • Storage: Reclast:
      • COMPATIBILITY
      • Reclast and Zometa
      • RATE OF ADMINISTRATION
      • Reclast
      • ACTIONS
      • Zoledronic Acid
      • Reclast
      • Zometa
      • INDICATIONS AND USES
      • Reclast
      • Limitation of use:
      • Zometa
      • Limitation of use:
      • CONTRAINDICATIONS
      • Reclast and Zometa
      • Reclast
      • PRECAUTIONS
      • Reclast and Zometa
      • Reclast
      • Zometa
      • Monitor: Reclast and Zometa:
      • Reclast:
      • Zometa:
      • Patient Education: Reclast and Zometa:
      • Reclast:
      • Zometa:
      • Maternal/Child:
      • Elderly:
      • DRUG/LAB INTERACTIONS
      • Reclast and Zometa
      • Zometa
      • SIDE EFFECTS
      • Reclast and Zometa
      • Reclast
      • Zometa
      • Post-Marketing:
      • Overdose:
      • ANTIDOTE
      • Reclast and Zometa
      • Zometa
      • APPENDIX A Recommendations for the Safe Use and Handling of Cytotoxic Drugs
      • APPENDIX B FDA Pregnancy Categories
      • APPENDIX D Information for Patients Receiving Immunosuppressive Agents
      • APPENDIX E Recently approved drugs
      • AMISULPRIDE
      • BREXANOLONE
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CEFIDEROCOL
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CETIRIZINE HYDROCHLORIDE
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CRIZANLIZUMAB-tmca INJECTION
      • USUAL DOSE
      • PEDIATRIC DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • CYSTEINE HYDROCHLORIDE
      • USUAL DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ENFORTUMAB VEDOTIN-ejfv
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • FAM-TRASTUZUMAB DERUXTECAN-nxki
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • GOLODIRSEN INJECTION
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • IMIPENEM, CILASTATIN, AND RELEBACTAM
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • LEFAMULIN
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • MELOXICAM INJECTION
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • ONASEMNOGENE ABEPARVOVEC-xioi
      • PEDIATRIC DOSE
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • POLATUZUMAB VEDOTIN-piiq
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • TEPROTUMUMAB-trbw
      • USUAL DOSE
      • DOSE ADJUSTMENTS
      • DILUTION
      • COMPATIBILITY
      • RATE OF ADMINISTRATION
      • ACTIONS
      • INDICATIONS AND USES
      • CONTRAINDICATIONS
      • PRECAUTIONS
      • DRUG/LAB INTERACTIONS
      • SIDE EFFECTS
      • ANTIDOTE
      • INDEX
      • A
      • B
      • C
      • D
      • E
      • F
      • G
      • H
      • I
      • J
      • K
      • L
      • M
      • N
      • O
      • P
      • Q
      • R
      • S
      • T
      • U
      • V
      • W
      • X
      • Y
      • Z

      Dateiformat: ePUB
      Kopierschutz: Adobe-DRM (Digital Rights Management)

      Systemvoraussetzungen:

      Computer (Windows; MacOS X; Linux): Installieren Sie bereits vor dem Download die kostenlose Software Adobe Digital Editions (siehe E-Book Hilfe).

      Tablet/Smartphone (Android; iOS): Installieren Sie bereits vor dem Download die kostenlose App Adobe Digital Editions (siehe E-Book Hilfe).

      E-Book-Reader: Bookeen, Kobo, Pocketbook, Sony, Tolino u.v.a.m. (nicht Kindle)

      Das Dateiformat ePUB ist sehr gut für Romane und Sachbücher geeignet - also für "fließenden" Text ohne komplexes Layout. Bei E-Readern oder Smartphones passt sich der Zeilen- und Seitenumbruch automatisch den kleinen Displays an. Mit Adobe-DRM wird hier ein "harter" Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.

      Bitte beachten Sie bei der Verwendung der Lese-Software Adobe Digital Editions: wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!

      Weitere Informationen finden Sie in unserer E-Book Hilfe.


      Download (sofort verfügbar)

      40,45 €
      inkl. 7% MwSt.
      Download / Einzel-Lizenz
      ePUB mit Adobe-DRM
      siehe Systemvoraussetzungen
      E-Book bestellen